In the current study, we examined and characterized the relationship between polymorphisms of the CYP4F2, ApoE, and CYP2A6 genes and the increased risk of cardiovascular diseases, in addition to their relation with the sensitivity and responsiveness to warfarin during the initiation and stabilization phases of therapy in a Jordanian population. This evidence concerns the gene CYP4F2 and cardiovascular disorder.